Biofrontera (BFRI) Interest Coverage Ratio (2020 - 2025)
Biofrontera's (BFRI) quarterly Interest Coverage Ratio came in at 6.27 in Q4 2025, up 102.2% year-on-year from 3.1 in Q4 2024, and up 109.99% quarter-over-quarter from 62.78 in Q3 2025.
Biofrontera (BFRI) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Biofrontera's Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 6.27 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 102.2% year-over-year to 6.27 in Q4 2025; TTM through Dec 2025 was 11.9, a 22.78% decrease from a year earlier, with the FY2025 full-year figure at 15.52, down 89.97% from the prior year.
- Interest Coverage Ratio advanced to 6.27 in Q4 2025 per BFRI's latest filing, from 62.78 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 7.51 in Q4 2021 and bottomed at 5581.0 in Q4 2022.
- The 5-year median for Interest Coverage Ratio is 40.26 (2021), against an average of 493.87.
- Across the five-year window, Interest Coverage Ratio surged 4612.3% in 2021 and sank 74376.33% in 2022, its largest moves.
- Year by year, Interest Coverage Ratio stood at 7.51 in 2021, then sank by 74376.33% to 5581.0 in 2022, then jumped by 98.56% to 80.52 in 2023, then sank by 254.36% to 285.33 in 2024, then soared by 102.2% to 6.27 in 2025.
- Per Business Quant, the three latest BFRI Interest Coverage Ratio figures stand at 6.27 (Q4 2025), 62.78 (Q3 2025), and 7.15 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 6.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.27 |
| Sep 30, 2025 | -62.78 |
| Jun 30, 2025 | -7.15 |
| Mar 31, 2025 | -37.89 |
| Dec 31, 2024 | -285.33 |
| Sep 30, 2024 | -16.53 |
| Jun 30, 2024 | -4.11 |
| Mar 31, 2024 | -3.85 |
| Dec 31, 2023 | -80.52 |
| Sep 30, 2023 | -107.44 |
| Jun 30, 2023 | -271.84 |
| Mar 31, 2023 | -2,746.00 |
| Dec 31, 2022 | -5,581.00 |
| Sep 30, 2022 | -36.39 |
| Mar 31, 2022 | -31.10 |
| Dec 31, 2021 | 7.51 |
| Sep 30, 2021 | -40.26 |
| Jun 30, 2021 | -43.38 |
| Mar 31, 2021 | -41.67 |
| Dec 31, 2020 | -0.17 |